stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Atrium Therapeutics IncRNA
$7.117.08%0.47

Atrium Therapeutics Inc (RNA)

Nov 19O6.70H7.02L6.65C7.02Vol67.81k

Atrium Therapeutics Inc Stock (RNA) Financials Data

*All numbers in millions
Period End Date2026-09-302026-06-302026-03-312025-12-312025-09-30
Period Length3 Months3 Months3 Months3 Months3 Months
Revenues
410.02%15.32
3.0019.640.8612.48
14.33%21.95
25.6236.92255.34201.28
Research and Development
10.08%13.80
15.3416.66166.60154.95
Operating Income/Loss
70.69%-6.63
-22.62-17.28-254.48-188.81
Nonoperating Income/Loss
2.84%2.36
2.430.6517.3814.36
Income/Loss From Continuing Operations Before Tax
-4.27
---237.1012.48
Income Tax Expense/Benefit
-
----
78.87%-4.27
-20.19-16.63-237.10-174.44
Attributable To Parent
78.87%-4.27
-20.19-16.63-237.10-174.44
Basic Average Shares
0.40%17.04
17.1117.115.43137.90
Diluted Average Shares
0.40%17.04
17.1117.115.43137.90
Basic Earnings Per Share
78.81%-0.25
-1.18-0.97-1.59-1.27
Diluted Earnings Per Share
78.81%-0.25
-1.18-0.97-1.59-1.27

Similar to RNA